NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|281362760|ref|NP_651646|]
View 

Neprilysin-like 21 [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
63-704 3.71e-174

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 512.68  E-value: 3.71e-174
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  63 ADPCNDFYAFSCGNYKRINSALSMQVvTTGVFETLTKGLNRKILKMLNTP-HDSHDTPEDIKVKHFYESCLQIKELNSTY 141
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAaSSAADSSAEQKAKDFYKSCMDEEAIEKLG 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 142 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAYRYGITPIFGIEVNKDLASNTRNRIYLGQQDFPLEARSMYVDD 221
Cdd:cd08662   80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 222 ATAVYRQKYRNNIQRILQrYLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVGELTQLLTVDEIQRRYsPTLDIDRL 301
Cdd:cd08662  152 ENAEIREAYKKYIAKLLE-LLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA-PSIDWKAY 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 302 LFVSMGER-ISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLIWEF-----------------VETPSDSPEKQMKA 363
Cdd:cd08662  230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskefrdarffygkALSGQKEPEPRWKR 309
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 364 CVDLTKKYFAKNLDNMFYRRYNNEKSSREIDNMWRQLKSTFNETLRSspaLNWIERPTRNLAMAKLQAMTLEV---NNYA 440
Cdd:cd08662  310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLEN---LDWMDEETKKKALEKLDAMKVKIgypDKWR 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 441 DDNFTEEFAELNLQSDDYVENVRYTSLLGAKQMREMLHKPAKPFEagsqLSYTPANI-----LIENTIKVPVALLQ-PFY 514
Cdd:cd08662  387 DYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPFF 462
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 515 iwSDVYPNAIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTAQ 593
Cdd:cd08662  463 --DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLTL 540
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 594 SENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDAHPSVKALQVSTDQHMPGR 673
Cdd:cd08662  541 GENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGK 610
                        650       660       670
                 ....*....|....*....|....*....|.
gi 281362760 674 FRVIGSLSNFEEFSKEFNCPAGSAMNPSEKC 704
Cdd:cd08662  611 FRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
63-704 3.71e-174

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 512.68  E-value: 3.71e-174
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  63 ADPCNDFYAFSCGNYKRINSALSMQVvTTGVFETLTKGLNRKILKMLNTP-HDSHDTPEDIKVKHFYESCLQIKELNSTY 141
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAaSSAADSSAEQKAKDFYKSCMDEEAIEKLG 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 142 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAYRYGITPIFGIEVNKDLASNTRNRIYLGQQDFPLEARSMYVDD 221
Cdd:cd08662   80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 222 ATAVYRQKYRNNIQRILQrYLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVGELTQLLTVDEIQRRYsPTLDIDRL 301
Cdd:cd08662  152 ENAEIREAYKKYIAKLLE-LLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA-PSIDWKAY 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 302 LFVSMGER-ISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLIWEF-----------------VETPSDSPEKQMKA 363
Cdd:cd08662  230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskefrdarffygkALSGQKEPEPRWKR 309
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 364 CVDLTKKYFAKNLDNMFYRRYNNEKSSREIDNMWRQLKSTFNETLRSspaLNWIERPTRNLAMAKLQAMTLEV---NNYA 440
Cdd:cd08662  310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLEN---LDWMDEETKKKALEKLDAMKVKIgypDKWR 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 441 DDNFTEEFAELNLQSDDYVENVRYTSLLGAKQMREMLHKPAKPFEagsqLSYTPANI-----LIENTIKVPVALLQ-PFY 514
Cdd:cd08662  387 DYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPFF 462
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 515 iwSDVYPNAIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTAQ 593
Cdd:cd08662  463 --DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLTL 540
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 594 SENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDAHPSVKALQVSTDQHMPGR 673
Cdd:cd08662  541 GENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGK 610
                        650       660       670
                 ....*....|....*....|....*....|.
gi 281362760 674 FRVIGSLSNFEEFSKEFNCPAGSAMNPSEKC 704
Cdd:cd08662  611 FRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
57-704 9.04e-74

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 251.61  E-value: 9.04e-74
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  57 SFMDQKADPCNDFYAFSCGNYKR---INSALSmqvvTTGVFETLTKGLN---RKILKMLNTPHDSHDTPEDiKVKHFYES 130
Cdd:COG3590   31 ANMDTSVRPGDDFYRYVNGGWLKttpIPADRS----RWGSFNELRERNEarlRAILEEAAAAPAAAGSDEQ-KIGDLYAS 105
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 131 CLQIKELNSTYSEKLKRLIAEFGTMpllegsswqeDDFDWLNTTARMAYRYGITPIFGIEVNKDLASNTRNRIYLGQQDF 210
Cdd:COG3590  106 FMDEAAIEALGLAPLKPDLARIDAI----------KDKADLAALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQGGL 175
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 211 PLEARSMYV--DDATAVYRQKYRNNIQRILQrYLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVgELT-QLLTVDE 287
Cdd:COG3590  176 GLPDRDYYLkdDEKSAEIRAAYVAHVAKMLE-LAGYDEADAAAAAEAVLALETALAKAHWSRVELRDP-EKTyNPMTVAE 253
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 288 IQRRYsPTLDIDRLlFVSMGERISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLIW--------EFVETPSD---- 355
Cdd:COG3590  254 LAKLA-PGFDWDAY-LKALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDsaapylskAFVDANFDfygk 331
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 356 --SPEKQMKA----CVDLT-------------KKYFaknldnmfyrrynNEKSSREIDNMWRQLKSTFNETLRsspALNW 416
Cdd:COG3590  332 tlSGQKEQRPrwkrAVALVngalgealgqlyvERYF-------------PPEAKARMEELVANLRAAYRERIE---NLDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 417 IERPTRNLAMAKLQAMTLEVNnYADDNftEEFAELNLQSDDYVENVRYTSLLGAKQMREMLHKPAKPFE---------Ag 487
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIG-YPDKW--RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEwgmtpqtvnA- 471
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 488 sqlSYTPANilieNTIKVPVALLQ-PFYiwsdvYPN---AIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSS 563
Cdd:COG3590  472 ---YYNPTM----NEIVFPAAILQpPFF-----DPKaddAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDR 539
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 564 SNFLKRRDCFTKQYGRYVY-DGIQLKESTAQSENIADNGGMRLAYTAYRKWYENQltlPNGAQDmtketlpnlRYTAKQL 642
Cdd:COG3590  540 AAFEARTKKLVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGK---EAPVID---------GFTGDQR 607
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 281362760 643 FFISFAQSWCNDAHPSVKALQVSTDQHMPGRFRVIGSLSNFEEFSKEFNCPAGSAM--NPSEKC 704
Cdd:COG3590  608 FFLGWAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRV 671
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
65-436 2.16e-73

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 242.59  E-value: 2.16e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760   65 PCNDFYAFSCGNYKRINSaLSMQVVTTGVFETLTKGLNRKILKMLNT-PHDSHDTPEDIKVKHFYESCLQIKELNSTYSE 143
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHP-IPADKSSWGTFDELRERNEKQLREILEEaAASESDPGAVEKAKDLYKSCMDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  144 KLKRLIAEFGtmplleGSSWQEDDFDWLNTTARMAyRYGITPIFGIEVNKDLASNTRNRIYLGQQDFPLEARSMYV---D 220
Cdd:pfam05649  80 PLKPLLDEIG------GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLkdrD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  221 DATAVYRQKYRNNIQRILQryLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVGELTQLLTVDEIQrRYSPTLDIDR 300
Cdd:pfam05649 153 EKSAEIREAYKAYIAKLLT--LLGASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQ-KLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  301 LL-FVSMGERISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLI---------------WEFVETPSDSPEK-QMKA 363
Cdd:pfam05649 230 YLnAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVrslapylsdefrdanFEFYGTLSGTKQRpRWKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 281362760  364 CVDLTKKYFAKNLDNMFYRRYNNEKSSREIDNMWRQLKSTFNETLRSspaLNWIERPTRNLAMAKLQAMTLEV 436
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDE---LDWMDEETKKKALEKLDAMTVKI 379
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
63-704 3.71e-174

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 512.68  E-value: 3.71e-174
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  63 ADPCNDFYAFSCGNYKRINSALSMQVvTTGVFETLTKGLNRKILKMLNTP-HDSHDTPEDIKVKHFYESCLQIKELNSTY 141
Cdd:cd08662    1 VDPCDDFYQYACGNWLKNHPIPADKS-SWGSFSELQDRNEEQLREILEEAaSSAADSSAEQKAKDFYKSCMDEEAIEKLG 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 142 SEKLKRLIAEFGTMPLLEGSSWqeddfdwlNTTARMAYRYGITPIFGIEVNKDLASNTRNRIYLGQQDFPLEARSMYVDD 221
Cdd:cd08662   80 LKPLKPLLDKIGGLPSLDDLAA--------ELLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 222 ATAVYRQKYRNNIQRILQrYLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVGELTQLLTVDEIQRRYsPTLDIDRL 301
Cdd:cd08662  152 ENAEIREAYKKYIAKLLE-LLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLA-PSIDWKAY 229
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 302 LFVSMGER-ISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLIWEF-----------------VETPSDSPEKQMKA 363
Cdd:cd08662  230 LKALGPPAdDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLapylskefrdarffygkALSGQKEPEPRWKR 309
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 364 CVDLTKKYFAKNLDNMFYRRYNNEKSSREIDNMWRQLKSTFNETLRSspaLNWIERPTRNLAMAKLQAMTLEV---NNYA 440
Cdd:cd08662  310 CVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLEN---LDWMDEETKKKALEKLDAMKVKIgypDKWR 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 441 DDNFTEEFAELNLQSDDYVENVRYTSLLGAKQMREMLHKPAKPFEagsqLSYTPANI-----LIENTIKVPVALLQ-PFY 514
Cdd:cd08662  387 DYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKPVDRTE----WSMSPQTVnayynPSLNEIVFPAGILQpPFF 462
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 515 iwSDVYPNAIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRDCFTKQYGRY-VYDGIQLKESTAQ 593
Cdd:cd08662  463 --DPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNYeVPPGLHVNGKLTL 540
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 594 SENIADNGGMRLAYTAYRKWYENQltlpngaqdmTKETLPNLRYTAKQLFFISFAQSWCNDAHPSVKALQVSTDQHMPGR 673
Cdd:cd08662  541 GENIADNGGLRLAYRAYKKWLKEN----------GPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGK 610
                        650       660       670
                 ....*....|....*....|....*....|.
gi 281362760 674 FRVIGSLSNFEEFSKEFNCPAGSAMNPSEKC 704
Cdd:cd08662  611 FRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
57-704 9.04e-74

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 251.61  E-value: 9.04e-74
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  57 SFMDQKADPCNDFYAFSCGNYKR---INSALSmqvvTTGVFETLTKGLN---RKILKMLNTPHDSHDTPEDiKVKHFYES 130
Cdd:COG3590   31 ANMDTSVRPGDDFYRYVNGGWLKttpIPADRS----RWGSFNELRERNEarlRAILEEAAAAPAAAGSDEQ-KIGDLYAS 105
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 131 CLQIKELNSTYSEKLKRLIAEFGTMpllegsswqeDDFDWLNTTARMAYRYGITPIFGIEVNKDLASNTRNRIYLGQQDF 210
Cdd:COG3590  106 FMDEAAIEALGLAPLKPDLARIDAI----------KDKADLAALLAALHRAGVGGLFGFGVDADLKNSTRYIAYLGQGGL 175
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 211 PLEARSMYV--DDATAVYRQKYRNNIQRILQrYLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVgELT-QLLTVDE 287
Cdd:COG3590  176 GLPDRDYYLkdDEKSAEIRAAYVAHVAKMLE-LAGYDEADAAAAAEAVLALETALAKAHWSRVELRDP-EKTyNPMTVAE 253
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 288 IQRRYsPTLDIDRLlFVSMGERISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLIW--------EFVETPSD---- 355
Cdd:COG3590  254 LAKLA-PGFDWDAY-LKALGLPAVDEVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDsaapylskAFVDANFDfygk 331
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 356 --SPEKQMKA----CVDLT-------------KKYFaknldnmfyrrynNEKSSREIDNMWRQLKSTFNETLRsspALNW 416
Cdd:COG3590  332 tlSGQKEQRPrwkrAVALVngalgealgqlyvERYF-------------PPEAKARMEELVANLRAAYRERIE---NLDW 395
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 417 IERPTRNLAMAKLQAMTLEVNnYADDNftEEFAELNLQSDDYVENVRYTSLLGAKQMREMLHKPAKPFE---------Ag 487
Cdd:COG3590  396 MSPETKAKALEKLAAFTPKIG-YPDKW--RDYSGLEIKRDDLVGNVLRASAFEYQRELAKLGKPVDRTEwgmtpqtvnA- 471
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 488 sqlSYTPANilieNTIKVPVALLQ-PFYiwsdvYPN---AIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSS 563
Cdd:COG3590  472 ---YYNPTM----NEIVFPAAILQpPFF-----DPKaddAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDR 539
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760 564 SNFLKRRDCFTKQYGRYVY-DGIQLKESTAQSENIADNGGMRLAYTAYRKWYENQltlPNGAQDmtketlpnlRYTAKQL 642
Cdd:COG3590  540 AAFEARTKKLVAQYDAYEPlPGLHVNGKLTLGENIADLGGLSIAYDAYKLSLKGK---EAPVID---------GFTGDQR 607
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 281362760 643 FFISFAQSWCNDAHPSVKALQVSTDQHMPGRFRVIGSLSNFEEFSKEFNCPAGSAM--NPSEKC 704
Cdd:COG3590  608 FFLGWAQVWRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRV 671
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
65-436 2.16e-73

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 242.59  E-value: 2.16e-73
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760   65 PCNDFYAFSCGNYKRINSaLSMQVVTTGVFETLTKGLNRKILKMLNT-PHDSHDTPEDIKVKHFYESCLQIKELNSTYSE 143
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHP-IPADKSSWGTFDELRERNEKQLREILEEaAASESDPGAVEKAKDLYKSCMDTDAIEKLGLK 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  144 KLKRLIAEFGtmplleGSSWQEDDFDWLNTTARMAyRYGITPIFGIEVNKDLASNTRNRIYLGQQDFPLEARSMYV---D 220
Cdd:pfam05649  80 PLKPLLDEIG------GPLANKDKFDLLETLAKLR-RYGVDSLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLkdrD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  221 DATAVYRQKYRNNIQRILQryLGVKMDLAKKTAKELIDFEVDLAQGLVDESEGLDVGELTQLLTVDEIQrRYSPTLDIDR 300
Cdd:pfam05649 153 EKSAEIREAYKAYIAKLLT--LLGASEEAAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQ-KLAPGIDWKA 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  301 LL-FVSMGERISDQIYEYNNRYQQNLVEVIKRTPKRTVANYIFFRLI---------------WEFVETPSDSPEK-QMKA 363
Cdd:pfam05649 230 YLnAAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVrslapylsdefrdanFEFYGTLSGTKQRpRWKR 309
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 281362760  364 CVDLTKKYFAKNLDNMFYRRYNNEKSSREIDNMWRQLKSTFNETLRSspaLNWIERPTRNLAMAKLQAMTLEV 436
Cdd:pfam05649 310 CVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDE---LDWMDEETKKKALEKLDAMTVKI 379
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
492-704 4.59e-52

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 179.15  E-value: 4.59e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  492 YTPAniliENTIKVPVALLQPFYiWSDVYPNAIMFGTLASLIGHELIHGFDDSGRKFDEKGNSKDWWDEKSSSNFLKRRD 571
Cdd:pfam01431   4 YQPN----RNEIVFPAAILQPPF-FDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 281362760  572 CFTKQY-GRYVYDGIQ-LKESTAQSENIADNGGMRLAYTAYRKwyenqltlpngAQDMTKETLPNL-RYTAKQLFFISFA 648
Cdd:pfam01431  79 CLIEQYsEYTPPDGTKcANGTLTLGENIADLGGLTIALRAYKK-----------LLSANETVLPGFeNLTPDQLFFRGAA 147
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 281362760  649 QSWCNDAHPSVKALQVSTDQHMPGRFRVIGSLSNFEEFSKEFNCPAGSAMNPSEKC 704
Cdd:pfam01431 148 QIWCMKQSPAEVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH